TABLE 6.

Association of CYP3A5 expressor status with post-transplant complications.

Complication	Occurrence	CYP3A5 non-expressor	CYP3A5 expressor	OR (95%CI)	p value
NODAT	YES	39	28	2.22 (1.14–4.33)	0.018 a
	NO	30	48
Rejection	NO	58	52	2.43 (1.08–5.44)	0.028 a
	YES	11	24
Tacrolimus toxicity	YES	22	18	1.51 (0.72–3.15)	0.266
	NO	46	57

^aStatistically significant.